Neurology Minute

Dr. Amanda Grenell discusses the main takeaways from her Zika virus update.

Dr. Jason Crowell highlights a commentary in Neurology: Clinical Practice on the imposter phenomenon and advancing women in neurology practice. You can read the commentary here: https://cp.neurology.org/content/9/2/155. 

Dr. Jeff Ratliff discusses FDA approval of new sIRNA therapies.

Dr. Elan Louis discusses tremor in the first part of a three-part series. To learn more, read the article "Tremor" by Dr. Louis in the August 2019 Movement Disorders issue of Continuum. 

Dr. Anastasia Zekeridou discusses the main takeaways from her paper on a new paraneoplastic biomarker. 

Prof. Robin Feldman discusses "evergreen" drug pricing, from her paper in the Journal of Law and the Biosciences, which you can read here: https://academic.oup.com/jlb/article/5/3/590/5232981.

Dr. Jill Farmer offers tips to give patients related to sex in Parkinson disease.

Dr. Michele Hu and discuss the take-home message from her and Dr. David Okai's paper on a longitudinal study of the severity of impulse control disorders in Parkinson disease and RBD.

Dr. Heidi Ledford, senior science reporter for Nature, discusses the next steps in gene editing technology.

Dr. Jill Farmer discusses recognition and treatment of non-motor symptoms of Parkinson disease.

Dr. Teshamae Monteith discusses the use of galcanezumab in the treatment of cluster headache.

Dr. Jill Farmer discusses "on" and "off" phenomena of Parkinson management.

Dr. Robert Zivadinov discusses the main takeaways from his paper on how cumulative gadodiamide administration leads to brain gadolinium deposition in early MS.

Dr. Michael D. Fox discusses the main takeaways from his paper on cervical dystonia. You can read the paper here: https://academic.oup.com/brain/article-abstract/142/6/1660/5491101?redirectedFrom=fulltext.  

Dr. Rae Bacharach discusses intravenous or subcutaneous immunoglobulin therapy in immune-mediated neurologic conditions.

Dr. Rae Bacharach discusses important points regarding application of the 2017 McDonald criteria for the diagnosis of MS. 

Dr. Rae Bacharach discusses oligoclonal bands in MS and other conditions and differentiating types of bands.

Dr. Barbara Weissman discusses the main points from her Neurology: Clinical Practice paper on recommendations for neurologists on the CDC's Guideline on Pediatric Mild Traumatic Brain Injury. 

Dr. Geoffrey Donnan discusses the main takeaways from his study on thrombolysis guided by perfusion imaging up to 9 hours after onset of stroke. Read his NEJM article here: https://www.nejm.org/doi/pdf/10.1056/NEJMoa1813046. 

Dr. Robert H. Gross discusses disease-modifying therapies in MS in the third part of a three-part series. To learn more, read the article "Monitoring, Switching, and Stopping Multiple Sclerosis Disease-Modifying Therapies" by Dr. Gross and Dr. John Corboy in the June 2019 Multiple Sclerosis and Other CNS Inflammatory Diseases issue of Continuum.